keyword
https://read.qxmd.com/read/38560604/covid-19-immunologic-antiviral-therapy-with-omalizumab-ciao-a-randomized-controlled-clinical-trial
#1
Michelle Le, Lauren Khoury, Yang Lu, Connor Prosty, Maxime Cormier, Mathew P Cheng, Robert Fowler, Srinivas Murthy, Jennifer L Y Tsang, Moshe Ben-Shoshan, Elham Rahme, Shirin Golchi, Nandini Dendukuri, Todd C Lee, Elena Netchiporouk
BACKGROUND: Omalizumab is an anti-immunoglobulin E monoclonal antibody used to treat moderate to severe chronic idiopathic urticaria, asthma, and nasal polyps. Recent research suggested that omalizumab may enhance the innate antiviral response and have anti-inflammatory properties. OBJECTIVE: We aimed to investigate the efficacy and safety of omalizumab in adults hospitalized for coronavirus disease 2019 (COVID-19) pneumonia. METHODS: This was a phase II randomized, double blind, placebo-controlled trial comparing omalizumab with placebo (in addition to standard of care) in hospitalized patients with COVID-19...
April 2024: Open Forum Infectious Diseases
https://read.qxmd.com/read/38557589/efficacy-and-safety-of-bilastine-vs-levocetirizine-for-the-treatment-of-chronic-idiopathic-urticaria-a-multicenter-double-blind-double-dummy-phase-iii-non-inferiority-randomized-clinical-trial
#2
JOURNAL ARTICLE
Xue Chen, Xiuping Han, Bo Cheng, Hui Li, Lingling Liu, Songmei Geng, Linfeng Li, Jie Li, Qing Guo, Guoyi Zhang, Hong Fang, Jianzhong Zhang
No abstract text is available yet for this article.
April 1, 2024: Chinese Medical Journal
https://read.qxmd.com/read/38502236/a-massive-attack-a-pediatric-case-of-macrophage-activation-syndrome-complicated-by-dic-as-an-onset-of-systemic-juvenile-idiopathic-arthritis-successfully-treated-with-anakinra-and-review-of-the-literature
#3
REVIEW
Anna Maeser, Malgorzata Biernacka-Zielinska, Elzbieta Smolewska
Macrophage activation syndrome (MAS) is one of the most severe complications of systemic juvenile idiopathic arthritis (sJIA). Around 10% of patients with sJIA exhibit systemic symptoms accompanied by macrophage activation syndrome (MAS), but it may occur subclinically in another 30-40%. In this article, we present a case of a 3-year-old girl diagnosed with sever MAS as an onset of sJIA complicated by disseminated intravascular coagulation (DIC). First symptoms of sJIA were observed about 5 months before setting the diagnose, and it was resembling urticaria...
March 19, 2024: Rheumatology International
https://read.qxmd.com/read/38488239/biologic-therapy-in-pediatric-chronic-rhinosinusitis-a-systematic-review
#4
REVIEW
Sara Rahavi-Ezabadi, Sheng Zhou, Stella E Lee, Elisabeth Ference, Anthony Magit, Shelby Leuin, Kawthar Mohamed, Nima Rezaei, Vijay A Patel
OBJECTIVE: Provide clinicians with current evidence for biologic therapy in children with chronic rhinosinusitis with nasal polyposis (CRSwNP). DATA SOURCES: PubMed, MEDLINE, Cochrane, and clinical trial registries. REVIEW METHODS: Key search terms related to biologic therapy in pediatric CRSwNP were identified via a structured query of current medical literature and clinical trial databases. CONCLUSIONS: There is a dearth of active clinical trials and research studies for biologics targeting pediatric CRSwNP...
March 15, 2024: Otolaryngology—Head and Neck Surgery
https://read.qxmd.com/read/38347809/a-survey-on-the-association-of-seizure-disorders-with-asthma-and-allergies-in-children
#5
JOURNAL ARTICLE
H Sadri, A Madanipour, N Toami, M Bakhtiari, H Montazerlotfelahi, E Zahmatkesh, A Zandifar, M Tavakol
Background. Little is known about the relationship between allergic diseases and seizure disorders including epilepsy. It is hypothesized that inflammation from allergic diseases may predispose children to seizures. the aim of this study is to investigate frequency of seizure disorder in children with asthma and allergy. Methods. A cross-sectional survey study of parents of 1300 children and adolescents under 20 years of age referred to the Allergy and Asthma Clinic of Imam Ali Hospital (Karaj) who were asked to complete a screening questionnaire for seizures in their children...
February 13, 2024: European Annals of Allergy and Clinical Immunology
https://read.qxmd.com/read/38174195/undiagnosed-celiac-disease-associated-with-antiphospholipid-syndrome-causing-infertility-and-osteoporosis
#6
Aljoharah Al Saud, Ziad F Rayes
Celiac disease and antiphospholipid syndrome are two conditions associated with infertility, but their coexistence is rarely reported. In this manuscript, we present the case of a 23-year-old woman initially presenting with urticaria and vitamin D deficiency, subsequently developing recurrent miscarriages and osteoporosis over a period of 13 years. After initially presenting with urticaria and vitamin D deficiency, she was diagnosed with idiopathic urticaria. Thirteen years later, the patient was diagnosed with antiphospholipid syndrome following multiple pregnancy losses and eventually underwent in vitro fertilization successfully with a diamniotic dichorionic pregnancy...
December 2023: Curēus
https://read.qxmd.com/read/38090791/integrative-approaches-to-sleep-management-in-skin-disease-systematic-review
#7
REVIEW
Vishnutheertha A Kulkarni, Isaiah Mojica, Vahram Gamsarian, Michelle Tahjian, David Liu, Tjinder Grewal, Yuyang Liu, Torunn E Sivesind, Peter Lio
BACKGROUND: Dermatological conditions, especially when severe, can lead to sleep disturbances that affect a patient's quality of life. However, limited research exists on the efficacy of treatments for improving sleep parameters in skin conditions. OBJECTIVE: The objective was to perform a systematic review of the literature on dermatological conditions and the treatments available for improving sleep parameters. METHODS: A literature review was performed using the PubMed, Ovid MEDLINE, Embase, Cochrane, and ClinicalTrials...
December 13, 2023: JMIR dermatology
https://read.qxmd.com/read/38088172/quantity-increase-and-functional-affinity-avidity-decrease-of-anti-fc%C3%AE%C2%B5ri-and-anti-ige-autoantibodies-in-chronic-spontaneous-urticaria
#8
JOURNAL ARTICLE
L Jörg, N Müller-Wirth, K Kammermann, O Stalder, W Pichle, O Hausmann
Background. Patients with autoimmune forms of chronic spontaneous urticaria (aiCSU) exhibit autoantibodies against the high-affinity IgE receptor (FcεRI) and IgE. As the presence of these autoantibodies does not correlate with disease activity, the functional affinity/avidity may be relevant in aiCSU. This exploratory study aimed to characterize the quantity and avidity of autoantibodies against IgE and FcεRI over 6 months. Methods. The serum of 49 patients with CSU and 30 healthy control subjects was obtained at baseline and 6 months...
December 13, 2023: European Annals of Allergy and Clinical Immunology
https://read.qxmd.com/read/38060717/intradermal-immunoglobulin-e-ige-injection-in-a-specific-interval-with-emollient-in-the-control-of-chronic-idiopathic-urticaria-and-allergic-rhinitis
#9
JOURNAL ARTICLE
Farhana Rashid Sumi, Md Abul Kalam A Bhuiyan, Md Abdul Mukit, Sarker Mahbub A Shamim, Rehnuma Tabassum Orthy, Saimun Jesmin
Background and objective: Urticaria is distinguished by the activation of mast cells and basophils via degranulation, predominantly induced by the cross-linkage of allergens with specific immunoglobulin E (IgE) antibodies. Several hypotheses propose that intradermal injections of IgE stimulate the production of antibodies that are specifically targeted towards the histamine/immunoglobulin complex. Subsequently, these antibodies exhibit binding affinity towards and exert inhibitory effects on the generation of histamine during the occurrence of allergic responses...
November 2023: Curēus
https://read.qxmd.com/read/38056692/low-prevalence-of-idiopathic-mast-cell-activation-syndrome-among-703-patients-with-suspected-mast-cell-disorders
#10
JOURNAL ARTICLE
Taleb Zaghmout, Laura Maclachlan, Nawfal Bedi, Theo Gülen
BACKGROUND: Idiopathic mast cell activation syndrome (iMCAS) is characterised by severe, episodic systemic mast cell (MC) activation and mediator-related symptoms, event-related increase in serum tryptase levels and response to MC-targeted therapies, in the absence of underlying IgE-mediated allergy or clonal MC disorder. Studies indicating its prevalence using evidence-based diagnostic criteria are currently lacking. OBJECTIVE: The present study aimed to assess prevalence, as well as clinical and laboratory features of patients with iMCAS...
December 4, 2023: Journal of Allergy and Clinical Immunology in Practice
https://read.qxmd.com/read/38025339/cold-induced-urticaria-after-black-ant-bite-anaphylaxis
#11
JOURNAL ARTICLE
Sara Mohamed, Hassan Mobayed
INTRODUCTION: Acquired cold-induced urticaria is a form of physical urticaria that is usually spontaneous. However, reports have shown that bees, wasps, or jellyfish stings can trigger it. We report the first case of cold-induced urticaria following black ant bite-induced anaphylaxis. CASE REPORT: A 41-year-old lady with no chronic illness with a known black ant bite allergy history. Three years ago, she sustained a black ant bite that required an emergency room visit to treat anaphylaxis...
2023: Qatar Medical Journal
https://read.qxmd.com/read/38025332/a-review-of-patch-test-data-over-the-period-of-eight-years-in-the-allergy-and-immunology-department-in-qatar
#12
JOURNAL ARTICLE
Sally Khalil, Sherin Rahim, Hassan Mobayed, Maryam Al-Nesf
BACKGROUND: Patch testing is the primary diagnostic approach for contact dermatitis,1 an inflammatory skin reaction caused by exposure to external irritants. The pathophysiology of contact dermatitis may entail an immunological response (hypersensitivity type IV), a non-immunological response (irritant contact dermatitis), or a mix of the two. The diagnosis of contact dermatitis requires a correlation between a positive patch test and clinical relevance.2 This study aims to determine the prevalence of allergy sensitization among adults in Qatar and the allergens most frequently associated with positive patch test findings...
2023: Qatar Medical Journal
https://read.qxmd.com/read/37952519/biomarkers-of-autologous-whole-blood-injection-efficacy-in-patients-with-chronic-spontaneous-urticaria-with-autoreactivity-a-preliminary-study
#13
Qiquan Chen, Jincheng Luo, Xianjie Yang, WenChieh Chen, Wenying Liu, Zhiqiang Song
INTRODUCTION: Chronic spontaneous urticaria (CSU) with autoreactivity is often resistant to antihistamines. Autologous whole blood injection (AWBI) has shown potential efficacy in the treatment of this disease, but it is controversial. It is necessary to screen patients who are suitable for this therapy in advance. This study aimed to identify biomarkers that predict the efficacy of AWBI treatment in CSU patients with autoreactivity. METHODS: A total of 30 patients with autologous serum skin test-positive CSU treated with AWBI were included in this study; urticaria activity score (UAS7) was recorded and the treatment response was judged based on it...
November 10, 2023: International Archives of Allergy and Immunology
https://read.qxmd.com/read/37739216/greens-appraisal-of-validated-stability-indicating-rp-hplc-method-and-forced-degradation-study-for-quantification-of-ebastine-in-wastewater-and-dosage-form
#14
JOURNAL ARTICLE
Manal A Almalki, Tahani Ya Alanazi, Samar M Mahgoub, Fatma I Abo El-Ela, Mahmoud A Mohamed
OBJECTIVES: Allergic rhinitis and chronic idiopathic urticaria are common conditions triggered by environmental irritants, stress, and certain foods. The FDA has recently announced that the efficacy and safety of Ebastine (EBS) have been thoroughly evaluated and confirmed. This study considered using various tools to assess their greenness. We used AGREEprep, analytical eco-scale (ESA), and analytical method volume intensity (AMVI) to evaluate the greenness of the validated stability-indicating method and a forced degradation study...
September 20, 2023: Annales Pharmaceutiques Françaises
https://read.qxmd.com/read/37736455/acquired-non-histaminergic-angioedema-with-c1q-autoantibody-and-urticaria-a-case-report
#15
Andrew P Kochvar, Gavin Cobb, Celina C Bernabe, Terry Levine
Acquired angioedema (AAE) is a rare disease with life-threatening complications. This pathology has classically been associated with medication use and B cell lymphoproliferative disorders. In this report, we describe a 61-year-old man with a six-year history of angioedema, unrelated to any known triggers or malignancy. Extensive workup has led to a diagnosis of idiopathic nonhistaminergic AAE with normal C1 inhibitor. The patient is currently being treated with lanadelumab, which has resolved the patient's symptoms...
August 2023: Curēus
https://read.qxmd.com/read/37689672/treatment-of-idiopathic-anaphylaxis-with-dupilumab-a-case-report
#16
JOURNAL ARTICLE
Elizabeth Pepper, Luke Pittman
BACKGROUND: Anaphylaxis is an acute, potentially life-threatening allergic reaction that typically occurs after exposure to a trigger, while idiopathic anaphylaxis (IA) occurs in the absence of a trigger. Acute management of both triggered anaphylaxis and IA relies on the use of epinephrine. In some patients with recurrent IA, glucocorticoid prophylaxis with prednisone can be effective. While there is currently no high quality evidence for the use of other prophylactic options to prevent recurrent IA, evolving data exists to support the consideration of biologics that target IgE or the Th2 pathway...
September 9, 2023: Allergy, Asthma, and Clinical Immunology
https://read.qxmd.com/read/37655364/bioequivalence-of-2-pediatric-formulations-of-fexofenadine-hydrochloride-oral-suspension
#17
JOURNAL ARTICLE
Clemence Rauch, Luiz Lucio, Beatrice Bois De Fer, Michele Lheritier-Barrand
Fexofenadine hydrochloride (HCl) is a second-generation, nonsedating, histamine H1-receptor antagonist used to manage seasonal allergic rhinitis and chronic idiopathic urticaria. A new oral pediatric suspension of fexofenadine HCl has been developed, with the preservative potassium sorbate replacing parabens. The objective of this phase 1 single-center, open-label, randomized, 2-treatment, full-replicated, 4-period, 2-sequence crossover study in healthy adult volunteers was to assess the bioequivalence of 30 mg of the new oral suspension of fexofenadine HCl (test) versus 30 mg of the marketed pediatric oral suspension of fexofenadine HCl (reference)...
September 1, 2023: Clinical Pharmacology in Drug Development
https://read.qxmd.com/read/37634890/neuroimmune-interplay-during-type-2-inflammation-symptoms-mechanisms-and-therapeutic-targets-in-atopic-diseases
#18
REVIEW
Brian Kim, Marc E Rothenberg, Xin Sun, Claus Bachert, David Artis, Raza Zaheer, Yamo Deniz, Paul Rowe, Sonya Cyr
Type 2 inflammation is characterized by overexpression and heightened activity of type 2 cytokines, mediators, and cells that drive neuroimmune activation and sensitization to previously subthreshold stimuli. The consequences of altered neuroimmune activity differ by tissue type and disease; they include skin inflammation, sensitization to pruritogens, and itch amplification in atopic dermatitis and prurigo nodularis; airway inflammation and/or hyperresponsiveness, loss of expiratory volume, airflow obstruction and increased mucus production in asthma; loss of sense of smell in chronic rhinosinusitis with nasal polyps; and dysphagia in eosinophilic esophagitis...
August 25, 2023: Journal of Allergy and Clinical Immunology
https://read.qxmd.com/read/37522366/a-case-of-hypocomplementemic-urticarial-vasculitis-syndrome-complicated-by-eosinophilic-pneumonia-a-case-report-and-review-of-the-literature
#19
REVIEW
Yuki Kaneko, Shujiro Hayashi, Ken Igawa
The primary symptom of urticarial vasculitis (UV), which is a histopathological leukocytoclastic vasculitis disease, is an eruption that resembles urticaria. Other organs may also experience accompanying symptoms. Lung lesions with UV are mostly obstructive pulmonary disease with smoking. However, the coexistence of eosinophilic pneumonia (EP) and complicated UV remains unclear. We report a man in his 70s with chronic obstructive pulmonary disease who attended our department with ring-shaped erythema, marginal edema, and pigmentation...
July 2023: Journal of International Medical Research
https://read.qxmd.com/read/37490396/leprosy-misdiagnosed-as-chronic-urticaria-in-a-migrant
#20
JOURNAL ARTICLE
Elisabetta Magnaterra, Ilaria Scandagli, Biancamaria Zuccaro, Vincenza Maio, Sara Simi, Daniela Massi, Paolo Fiallo, Stefano Francalanci, Elisa Difonzo, Luigi Pisano
A Sri Lankan man presents with the suspicion of chronic idiopathic urticaria with angioedema, but facial swelling leads to an unexpected discovery. Thickened skin, nodules, and neurological symptoms reveal the true culprit. Leprosy challenges diagnosis in nonendemic regions. Vigilance and comprehensive assessment are crucial to unmask this great imitator.
July 25, 2023: Journal of Travel Medicine
keyword
keyword
65417
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.